Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-PI3K/Akt/mTOR Pathway-PI3K-Parsaclisib
Parsaclisib

Chemical Structure : Parsaclisib

CAS No.: 1426698-88-5

Parsaclisib (INCB050465, INCB 050465)

Catalog No.: PC-60527Not For Human Use, Lab Use Only.

Parsaclisib (INCB050465) is a potent and highly selective PI3Kδ inhibitor with IC50 of < 1 nM (SPA).

Packing Price Stock Quantity
5 mg $258 In stock
10 mg $398 In stock
25 mg $588 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Parsaclisib (INCB050465) is a potent and highly selective PI3Kδ inhibitor with IC50 of < 1 nM (SPA).
Parsaclisib (INCB050465) displayed cellular activity in SU-DHL-6 viability (IC50=1.6 nM) and Pfeiffer proliferation (IC50=2.5 nM).
Parsaclisib (INCB050465) is very selective over the other PI3K isoforms (PI3Kα/β/γ FB IC50 vuales >10,000 nM), exhibits selectivity over a panel of 197 kinases and is very potent in the RAMOS cellular and human whole blood basophil assays.
Parsaclisib (INCB050465) dosed orally twice daily significantly inhibited Pfeiffer xenograft tumor growth at 1 mg/kg, with profound inhibition of the phosphorylation of AKT at Ser473, a marker of PI3Kδ activity, observed in mice models.|
Parsaclisib (INCB050465) directly blocks PI3K signaling-mediated cell proliferation in B-cell lines in vitro and in vivo and indirectly controls tumor growth by lessening immunosuppression through regulatory T-cell inhibition in a syngeneic lymphoma model.

Physicochemical Properties

M.Wt 432.88
Formula C20H22ClFN6O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

>200 mM in DMSO (>86 mg/mL)

Chemical Name/SMILES

(4R)-4-{3-[(1S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4- d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy- 6-fluorophenyl}pyrrolidin-2-one

References

1. Shin N, et al. J Pharmacol Exp Ther. 2020 Jul;374(1):211-222.
2. Forero-Torres A, et al. Blood. 2019 Apr 18;133(16):1742-1752.
3. Yue EW, et al. ACS Med Chem Lett. 2019 Oct 17;10(11):1554-1560.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: